Charpentier collects CRISPR/Cas9 tech patents for gene editing in Japan and US
ERS Genomics says its patent applications have been approved in the US and Japan, and the pace of license deals has increased to up to four per month.
Top Headlines
Global Industry News
-
MediPharma develops ‘smart’ blister to improve patient compliance
from Outsourcing-Pharma.com
-
AI-informed virtual assistant to help solve ‘stubborn problems,’ says Saama
from Outsourcing-Pharma.com
-
Serialisation legislation could improve recall process for drugmakers, says exec
from in-PharmaTechnologist.com
-
Alcami supporting commercial supply of Flexion’s first FDA-approved product
from in-PharmaTechnologist.com
Hot Topics
-
Cellectis bakes safety switch into CAR-T to stop runaway responses
Cell & Gene Therapies
-
Eisai targets dementia drug discovery with US research facility
Pipelines
-
ADC Bio: Biotech may 'hold the key' to innovation adoption
Antibody-drug conjugates
-
GE grows FlexFactory presence in China with another cell therapy plant deal
Cell & Gene Therapies
